Previous 10 | Next 10 |
Features include Zeno SWATH DIA, stMRM, an integrated central console and accessibility across 9 languages At ASMS 2022, SCIEX , a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches SCIEX OS software v3.0, a s...
Enabling biomarker discovery and translation through increased sensitivity, throughput and robustness. SCIEX , a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches Zeno SWATH DIA, a significant step forward in...
Founded by value investor Wally Weitz in 1983, Weitz Investment Management, Inc. is a boutique, employee-owned asset management firm headquartered in Omaha, Nebraska. The Value Fund’s Institutional Class returned -7.96% for the first quarter. Our companies are generally rep...
Danaher has outperformed its benchmark for the past several decades. They successfully apply the concept of extreme focus and profit orientation in their acquisitions. Rock-solid key metrics show the quality of the company, which continues to grow. Despite a high valuation, th...
In this article, I start by explaining that a low-volatility strategy is a great way to generate long-term (outperforming) wealth. Thanks to outperformance in bear markets and strong growth in bull markets, low-volatility stocks tend to be the best performers. Danaher is my favori...
Dan Loeb's 13F portfolio value decreased from $14.33B to $7.68B this quarter. The number of positions decreased from 92 to 75. Third Point added CSX & Alcoa while dropping Accenture and Upstart Holdings. They also increased EQT Corporation and Zendesk while reducing Amazon.com and...
Citi says investors should still be looking for quality stocks when dealing with the Fed rate hike cycle and a possible recession. "Admittedly, stocks with high-quality attributes have not been immune from this year’s volatility," equity strategist Scott Chronert wrote in a note. "Why?...
This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management. After the Q1-2022 13F filings the consensus holdings were updated, 10 stocks were removed and 8 added from the univ...
Biopharmaceutical stocks have undergone a dramatic correction over the past six months, with the XBI declining by 45%. The decline was appropriate, given the number of companies that went public in 2021 with preclinical data and a valuation exceeding $1 billion. Not only would the...
Danaher Corporation (DHR) Bank of America Securities Health Care Conference May 11, 2022 01:00 PM ET Company Participants Rainer Blair - CEO Conference Call Participants Derik De Bruin - Bank of America Mike Ryskin - Bank of America Presentation Derik De Bruin [Call Starts Abruptly] I’...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...